SEC Form 4 · accession 0001104659-26-077864
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn A. Tetrault
Director
Period of report
Jun 23, 2026
Accepted (ET)
Jun 25, 2026 · 6:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649904
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 23, 2026 | M | 4,712 | — | A | 11,712 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 23, 2026 | M | 4,712 | D | — | — | Common Stock | 4,712 | 0 | D |
| Stock Option (right to buy)F3 | $107.55 | Jun 24, 2026 | A | 3,691 | A | — | Jun 23, 2036 | Common Stock | 3,691 | 3,691 | D |
| Restricted Stock UnitsF1,F4 | — | Jun 24, 2026 | A | 2,324 | A | — | — | Common Stock | 2,324 | 2,324 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2The restricted stock units are fully vested. The restricted stock units have no expiration date.
- F3The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date.
- F4The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.